Pramod Reddy Patil
Global Development Medical Director @AstraZeneca
Signup · Get unlimited contacts
WORK HISTORY
Global Development Medical Director @AstraZeneca
Bengaluru, IN
Is accountable to the Global Clinical Head (GCH) or delegate for the medical aspects and designs of studies- Is responsible for driving decisions within Study Team (ST) remits together with other ST members and for solving medical issues in the study team- Is accountable for delivery of the clinical components of all relevant study documents- Is accountable for ensuring that safety surveillance on a study level- Is medically accountable for international investigator meetings, and supports Marketing Companies (MC) in national activities- Collaborates seamlessly and efficiently with global colleagues at other R&D sites- May be accountable to GCH (or delegate) and leadership for identifying risks and proposing mitigation strategies to deliver successful Phase II, IV or Life Cycle Management studies
EDUCATION
Mahadevappa Rampure Medical College
Bachelor of Medicine, Bachelor of Surgery (MBBS), Medicine
IMA College of general Practioners
Fellowship Certificate in Diabetology, Endocrinology, Diabetes and Metabolism Residency Program
Prathima Institute of Medical Scienes
MD, Pharmacology
University of Basel
Diploma of Advanced Studies (DAS) in Pharmaceutical Medicine, Pharmaceutical Medicine
SKILLS
ABOUT PRAMOD REDDY PATIL
I am an experienced Clinical Pharmacologist with a notable career in the pharmaceuticals and healthcare industry. My expertise includes leading Bioavailability and Bioequivalence/Phase 1 studies as a Principal Investigator across various therapeutic areas. In Pharmacovigilance, I have played a key role as a Safety Physician, overseeing the preparation of PBRERs/PSURs and conducting comprehensive medical reviews of ICSRs across multiple therapeutic fields.At AstraZeneca, I have acted as a representative for the Global Clinical Head in License to Operate activities for a range of cardiovascular and diabetic products. Currently, I am the Global Development Medical Director, serving as a Study Physician for Eplontersen, which is a treatment for Transthyretin Amyloidosis (ATTR). I also represent the Global Clinical Head in MAAs and License to Operate activities for the diabetic product SIDAPVIA (Dapagliflozin/Sitagliptin).
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.